ARCHIVES

High Cervical Cancer Rates Indicate Access Problems

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

Conversation with The Cancer Letter: Einhorn: “I Still Harbor Hope For Similar Success Stories”

October 24, 2014

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007

Adherez Issued U.S. Patent for Catenin Molecule Inhibition.

July 4, 2003

PhRMA Tightens DTC Restrictions, But Dingell Says It’s Not Enough.

December 12, 2008

House Members Who Voted for Veto

January 3, 1986

ACCC Seeks Greater Role In Clinical Research Priorities; Suggests Up To 400 Cancer Program

April 13, 1979